Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway

References

• Ahn J, Won M, Choi J-H, Kim YS, Jung C-R, Im D-S, Kyun M-L, Lee K, Song K-B, Chung K-S, et al. 2013. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21Cip1 downregulation are required for shikonin-induced apoptosis. Apoptosis. 18:870–881.
   PubMed Web of Science ®Google Scholar
• Cui X-R, Tsukada M, Suzuki N, Shimamura T, Gao L, Koyanagi J, Komada F, Saito S. 2008. Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones. Eur J Med Chem. 43:1206–1215.
   PubMed Web of Science ®Google Scholar
• Ganz PA, Romond EH, Cecchini RS, Rastogi P, Geyer CE, Swain SM, Jeong J-H, Fehrenbacher L, Gross HM, Brufsky AM, et al. 2017. Long-term follow-up of cardiac function and quality of life for patients in NSABP protocol B-31/NRG oncology: a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel with AC followed by paclitaxel and trastuzumab in patients with node-positive breast cancer with tumors overexpressing human epidermal growth factor receptor 2. J Clin Oncol. 35:3942–3948.
   PubMed Web of Science ®Google Scholar
• Green BD, Jabbour AM, Sandow JJ, Riffkin CD, Masouras D, Daunt CP, Salmanidis M, Brumatti G, Hemmings BA, Guthridge MA, et al. 2013. Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations. Cell Death Differ. 20:1341–1349.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of Cancer: The Next Generation. Cell. 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hasenoehrl C, Schwach G, Ghaffari-Tabrizi-Wizsy N, Fuchs R, Kretschmer N, Bauer R, Pfragner R. 2017. Antitumor effects of shikonin derivatives on human medullary thyroid carcinoma cells. Endocr Connect. 6:53–62.
   PubMed Web of Science ®Google Scholar
• He F, Wu HN, Cai MY, Li CP, Zhang X, Wan Q, Tang SB, Cheng JD. 2014. Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway. Oncol Lett. 7:2047–2052.
   PubMed Web of Science ®Google Scholar
• Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al. 1994. Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen. J Clin Oncol. 12:553–559.
   PubMed Web of Science ®Google Scholar
• Hu Y, Jiang Z, Leung KS, Zhao Z. 2006. Simultaneous determination of naphthoquinone derivatives in Boraginaceous herbs by high performance liquid chromatography. Analyt Chim Acta. 577:26–31.
   PubMed Web of Science ®Google Scholar
• Jeung Y-J, Kim H-G, Ahn J, Lee H-J, Lee S-B, Won M, Jung C-R, Im J-Y, Kim B-K, Park S-K, et al. 2016. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300. Biochim Biophys Acta. 1863:2584–2593.
   PubMed Web of Science ®Google Scholar
• Kim JH, Park SJ. 2016. Target therapy in unresectable or metastatic colorectal cancer. Korean J Gastroenterol = Taehan Sohwagi Hakhoe Chi. 68:303–311.
   PubMedGoogle Scholar
• Klanova M, Andera L, Brazina J, Svadlenka J, Benesova S, Soukup J, Prukova D, Vejmelkova D, Jaksa R, Helman K, et al. 2016. Targeting of BCL2 family proteins with ABT-199 and homoharringtonine reveals BCL2- and MCL1-dependent subgroups of diffuse large B-cell lymphoma. Clin Cancer Res. 22:1138–1149.
   PubMed Web of Science ®Google Scholar
• Ko FN, Lee YS, Kuo SC, Chang YS, Teng CM. 1995. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma. Biochim Biophys Acta. 1268:329–334.
   PubMed Web of Science ®Google Scholar
• Kumar D, Shankar S, Srivastava RK. 2014. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett. 343:179–189.
   PubMed Web of Science ®Google Scholar
• Kuo HM, Hsia TC, Chuang YC, Lu HF, Lin SY, Chung JG. 2004. Shikonin inhibits the growth and N-acetylation of 2-aminofluorene in Helicobacter pylori from ulcer patients. Anticancer Res. 24:1587–1592.
   PubMed Web of Science ®Google Scholar
• Kutny MA, Alonzo TA, Gerbing RB, Wang Y-C, Raimondi SC, Hirsch BA, Fu CH, Meshinchi S, Gamis AS, Feusner JH, et al. 2017. Arsenic trioxide consolidation allows anthracycline dose reduction for pediatric patients with acute promyelocytic leukemia: report from the Children's Oncology Group Phase III Historically Controlled Trial AAML0631. J Clin Oncol. 35:3021–3029.
   PubMed Web of Science ®Google Scholar
• Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W. 2012. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell. 149:1269–1283.
   PubMed Web of Science ®Google Scholar
• Li T, Yan F, Wang R, Zhou H, Liu L. 2013. Suppresses human T lymphocyte activation through inhibition of IKKβ activity and JNK phosphorylation. Evid-Based Compl Altern Med. 2013:379536.
   PubMed Web of Science ®Google Scholar
• Lin TJ, Lin HT, Chang WT, Mitapalli SP, Hsiao PW, Yin SY, et al. 2015. Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components. Mol Cancer. 24:174.
   Web of Science ®Google Scholar
• Longley DB, McDermott U, Johnston PG. 2003. Predictive markers for colorectal cancer: current status and future prospects. Clin Colorectal Cancer. 2:223–230.
   PubMedGoogle Scholar
• Lu D, Qian J, Li W, Feng Q, Pan S, Zhang S. 2015. β-Hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling. Oncol Lett. 10:3434–3442.
   PubMed Web of Science ®Google Scholar
• Lukesh JC, Carney DW, Dong H, Cross RM, Shukla V, Duncan KK, Yang S, Brody DM, Brütsch MM, Radakovic A, et al. 2017. Vinblastine 20' amides: synthetic analogues that maintain or improve potency and simultaneously overcome Pgp-derived efflux and resistance. J Med Chem. 60:7591–7604.
   PubMed Web of Science ®Google Scholar
• McQuade RM, Stojanovska V, Bornstein JC, Nurgali K. 2017. Colorectal cancer chemotherapy: the evolution of treatment and new approaches. Curr Med Chem. 24:1537–1557.
   PubMed Web of Science ®Google Scholar
• Ozgen U, Coskun M, Kazaz C, Secen H. 2004. Naphthoquinones from the roots of Onosma argentatum Hub.-Mor. (Boraginaceae). Turk J Chem. 28:451–454.
   Web of Science ®Google Scholar
• Pang Y, Si M, Sun B, Niu L, Xu X, Lu T, Yuan H, Lou H. 2014. DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway. Food Chem Toxicol. 69:163–174.
   PubMed Web of Science ®Google Scholar
• Popolo A, Pinto A, Daglia M, Nabavi SF, Farooqi AA, Rastrelli L. 2017. Two likely targets for the anticancer effect of indole derivatives from cruciferous vegetables: PI3K/Akt/mTOR signaling pathway and the aryl hydrocarbon receptor. Semin Cancer Biol. 46:132–137.
   PubMed Web of Science ®Google Scholar
• Qian DC, Xiao X, Byun J, Suriawinata AA, Her SC, Amos CI, Barth RJ. 2017. PI3K/Akt/mTOR signaling and plasma membrane proteins are implicated in responsiveness to adjuvant dendritic cell vaccination for metastatic colorectal cancer. Clin Cancer Res. 23:399–406.
   PubMed Web of Science ®Google Scholar
• Qiu H-Y, Wang F, Wang X, Sun W-X, Qi J-L, Pang Y-J, Yang R-W, Lu G-H, Wang X-M, Yang Y-H, et al. 2017. Design, synthesis, and biological evaluation of chalcone-containing shikonin derivatives as inhibitors of tubulin polymerization. ChemMedChem. 12:399–406.
   PubMed Web of Science ®Google Scholar
• Qiu H-Y, Zhu X, Luo Y-L, Lin H-Y, Tang C-Y, Qi J-L, Pang Y-J, Yang R-W, Lu G-H, Wang X-M, et al. 2017. Identification of new shikonin derivatives as antitumor agents targeting STAT3 SH2 domain. Sci Rep. 7:2863.
   PubMed Web of Science ®Google Scholar
• Rodon J, Dienstmann R, Serra V, Tabernero J. 2013. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol. 10:143–153.
   PubMed Web of Science ®Google Scholar
• Su L, Liu L, Wang Y, Yan G, Zhang Y. 2014. Long-term systemic toxicity of shikonin derivatives in Wistar rats. Pharm Biol. 52:486–490.
   Web of Science ®Google Scholar
• Tang SW, Chen A, Zhou XJ, Zeng L, Liu MY, Wang X. 2017. Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay. Toxicol Lett. 281:74–83.
   PubMed Web of Science ®Google Scholar
• Turati F, Bravi F, Di Maso M, Bosetti C, Polesel J, Serraino D, Dalmartello M, Giacosa A, Montella M, Tavani A, et al. 2017. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and colorectal cancer risk. Eur J Cancer. 85:86–94.
   PubMed Web of Science ®Google Scholar
• van Hazel GA, Pavlakis N, Goldstein D, Olver IN, Tapner MJ, Price D, Bower GD, Briggs GM, Rossleigh MA, Taylor DJ, et al. 2009. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol. 27:4089–4095.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck B, Stephens L, Hawkins P. 2012. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 13:195–203.
   PubMed Web of Science ®Google Scholar
• Woo SU, Sangai T, Akcakanat A, Chen H, Wei C, Meric-Bernstam F. 2017. Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer. Oncogenesis. 6:e385.
   PubMed Web of Science ®Google Scholar
• Yu C-C, Hung S-K, Lin H-Y, Chiou W-Y, Lee M-S, Liao H-F, Huang H-B, Ho H-C, Su Y-C. 2017. Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo. Oncotarget. 8:68641–68653.
   PubMedGoogle Scholar
• Yu Z, Wang R, Xu L, Dong J, Jing Y. 2008. N-(beta-Elemene-13-yl)tryptophan methyl ester induces apoptosis in human leukemia cells and synergizes with arsenic trioxide through a hydrogen peroxide dependent pathway. Cancer Lett. 269:165–173.
   PubMed Web of Science ®Google Scholar
• Yuan Z-Q, Chen W-L, You B-G, Liu Y, Yang S-d, Li J-Z, Zhu W-J, Zhou X-F, Liu C, Zhang X-N, et al. 2017. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor. J Control Release. 268:198–211.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kwok-Shing Ng P, Kucherlapati M, Chen F, Liu Y, Tsang YH, de Velasco G, Jeong KJ, Akbani R, Hadjipanayis A, et al. 2017. A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations. Cancer Cell. 31:820–832.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhou Y, Wang L, Li M, Shi D, Li D, Wang J. 2017. Shikonin alleviates the biotoxicity produced by pneumococcal pneumolysin. Life Sci. 15:1–7.
   Web of Science ®Google Scholar